---
schema_version: "secwatch.filing_event.v1"
accession: "0001104659-24-075375"
form_type: "8-K"
ticker: "UTHR"
cik: "0001082554"
company_name: "UNITED THERAPEUTICS Corp"
filed_at: "2024-06-27T23:59:59+00:00"
generated_at: "2026-06-01T00:55:44.215824+00:00"
event_type: "leadership"
sentiment: "neutral"
materiality_score: 0.5
calibrated_materiality_score: 0.5
confidence: "high"
source: SEC EDGAR
---

# United Therapeutics shareholders elect Jan Malcolm to board, approve stock plan amendment adding 1.32M shares

## Summary
- Jan Malcolm, former Minnesota Health Commissioner, elected to board; replaces Prof. Katherine Klein who did not stand for re-election.
- Shareholders approved amendment to 2015 Stock Incentive Plan: adds 1,320,000 shares, extends expiration to April 25, 2034.
- All 11 director nominees elected; advisory resolution on executive compensation passed with 94.8% of votes cast.
- Ratification of Ernst & Young as independent auditor for 2024 approved by shareholders.

## SEC filing metadata
- accession: 0001104659-24-075375
- form_type: 8-K
- ticker: UTHR
- cik: 0001082554
- company_name: UNITED THERAPEUTICS Corp
- filed_at: 2024-06-27T23:59:59+00:00
- event_type: leadership
- sentiment: neutral
- materiality_score: 0.5
- calibrated_materiality_score: 0.5
- confidence: high
- sec_items: 5.02, 5.07, 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1082554/000110465924075375/0001104659-24-075375-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1082554/000110465924075375/tm2418313d1_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001104659-24-075375
- JSON: https://secwatch.observer/filing/0001104659-24-075375.json
- Plain text: https://secwatch.observer/filing/0001104659-24-075375.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.